Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mitra Angkasa Sejahtera Tbk. (BAUT) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Mitra Angkasa Sejahtera Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Mitra Angkasa Sejahtera Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Mitra Angkasa Sejahtera Tbk. trades at Rp29 (market cap 134.41B, 984.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Mitra Angkasa Sejahtera Tbk. is more actively traded (984.9K versus 214.9K). Which is the better fit depends on your goals.

BAUTOBAT
Market Cap
134.41B164.65B
Volume
984.9K214.9K
Lot
9.85K2.15K
Turnover
28.4M51.97M
Average Price
28.84241.85
Value
28.4M51.97M
Indicative Equilibrium Price
29240
Indicative Equilibrium Volume
2.57K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BAUT
View details
OBAT
View details

About Mitra Angkasa Sejahtera Tbk.

PT Mitra Angkasa Sejahtera Tbk (“the Company”) is established based on Deed of Establishment No. 63 dated November 19, 2012 made by Doktorandus Wijanto Suwongso, S.H., Notary in Jakarta. The Company started its commercial operations in 2016.

Read more on BAUT

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT